Athens, November 1st., 2023 – M.S. Jacovides Hellas has signed a distributor agreement with the Finnish company Bittium Biosignals Ltd., a subsidiary of Bittium Corporation, for the promotion and distribution in Greece of its innovative Bittium BrainStatus™, a wireless compact electroencephalogram (EEG) recording system for the monitoring of the electrical activity of the brain in real time.
Bittium’s BrainStatus™ device is a practical and compact wireless electroencephalogram (EEG) measurement and recording system that allows direct measurement of brains’ electrical activity in real time, both in field conditions and in hospitals’ Intensive Care Units. Bittium BrainStatus™ technology, with its quick and easy application, allows the instantaneous recording of brain activity in intensive care conditions and allows rapid diagnosis of conditions that require focused therapeutic interventions such as seizure-free epileptic state, cerebral ischemia, etc.
This new collaboration is part of M.S. Jacovides Hellas’s strategic plan to further develop partnerships with leading med-tech companies offering new innovative medical devices that improve patient quality of life.
Bittium Corporation, headquartered in Oulu, Finland, was founded in 1985 and is listed on the Nasdaq Helsinki Exchange. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurology, and sleep medicine. In addition, Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35-year legacy of expertise in advanced radio communication technologies.
M.S.Jacovides Hellas S.A., a member of MSJ Group, was founded in Athens in 1982 and its activities are focused on the import, promotion, distribution and support of high-tech medical equipment in the fields of Hematology and Blood Transfusion, Advanced Patient Care with applications in Anesthesia, Intensive Care, Pulmonology and Thoracic Surgery, as well as in Minimally Invasive Cardiology, Radiology & Oncology.
For more information please contact:
IKON Porter Novelli, Bia Enotiadi, email@example.com +30 210 67 84 356